David Pelz, MD, FRCPC

Academic Appointment: Professor Emeritus

Base Hospital: University Hospital

Area of Interest: Neuroradiology, CT, MR, cartoid ultrasound, angiography

Fellowship: Neuroradiology, University of Western Ontario (1981-82)

Radiology Residency: University of Western Ontario (1977-81)

Rotating Internship: Victoria Hospital, London, Ontario (1975-76)

Medical School: University of Western Ontario (1975)

Undergraduate Degree: BSc Natural Sciences, University of Western Ontario (1971)

Research Interests:

-A Phase II study of the safety and efficacy of Terifluomide (HMR1726) in Multiple Sclerosis with relapses: HMR1726D/2201
-A Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multi-Centre study to determine the safety and efficacy of Natalizumab in Subjects with Relapsing Resmitting Multiple Sclerosis
-Double-blind, Placebo-controlled, Randomized, Parallel group, Multi-centre Phase III study in patients with a first clinical demyelinating event suggestive of Multiple Sclerosis to evaluate the safety, tolerability, and efficacy of 8 MIU (250 mg) interferon beta-1b (Betaseron) given subcutaneously every other day over a period of up to 24 months
-Three-dimentional x-ray imaging for vascular disease therapy
-CREST (Carotid Revascularization Endarterectomy vs. Stenting Trial) multi-centre trial

Contact email: david.pelz@lhsc.on.ca

Administrative Assistant: Cathy Carlisle (cathy.carlisle@lhsc.on.ca)

Also from this web page:

Finding Your Way